Advanced Search

Study Preview



Study Title and Description

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
Author Delmas PD., Bjarnason NH., Mitlak BH., Ravoux AC., Shah AS., Huster WJ., Draper M., Christiansen C.
Country Hôpital Edouard Herriot, INSERM Research Unit 403, Lyons, France.
Year 1997
Numbers Pubmed ID: 9385122

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.